Skip to main content
Fig. 6 | BMC Neurology

Fig. 6

From: Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain

Fig. 6

Migraine patients managed by a neurologist per type of treatment initiated between January 2015 and December 2016 and time until referral (Cohorts C, D and E). CGRP, Calcitonin gene-related peptide; GP, General Practitioner. a. Treatments initiated between January 2015 and December 2016. Patients have been followed up since the first analyzed treatment found in the inclusion period until the last month with available data (April 2022). Only the treatments mentioned in the respective cohort have been included in the analyses. b. Time until first visit to the neurologist, regardless of whether there were previous visits to other specialties. c. Analysis performed up until the third visited specialty

Back to article page